During his time at the Children’s Hospital of Philadelphia/University of Pennsylvania is when he first consulted with Dr. Cooper regarding giant cell myocarditis in a previously health teenager, that then also recurred in a transplanted heart. This was also the first time that Dr. Nandi lost a patient to viral myocarditis, cementing in his mind the need to better understand and manage this clinical entity. He is excited to further the mission of the Myocarditis Foundation.
Brief info
Deipanjan “Deip” Nandi, was born outside of Chicago and grew up in north Texas, before matriculating at Harvard for his undergraduate honors degree in Biochemistry. From there he went to Duke University for medical school, while taking time to complete a Masters in Health Policy at the London School of Economics as a US-UK Fulbright Scholar. After completing his residency and chief residency in pediatrics at C.S. Mott Children’s Hospital at the University of Michigan in Ann Arbor, he completed his cardiology fellowship and advanced fellowships in heart failure, mechanical support and transplant at the Children’s Hospital of Philadelphia/University of Pennsylvania. After completing his training, he was recruited to Nationwide Children’s Hospital at the Ohio State University in Columbus, Ohio, where he is currently an Associate Professor of Pediatric Cardiology and is the Medical Director of the Pediatric & Adult Advanced Cardiac Therapies (PAACT) Program. He has held leadership positions locally and nationally, including within the Pediatric Heart Transplant Society and the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) learning collaborative, and has undertaken significant research in the field, with over 60 publications to date. Minimizing pediatric morbidity & mortality and understanding myocardial inflammation further with current gene therapy and other emerging therapies are passions of his.